Skip to main content
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

WATCH: Australian Health Official Admits “Sudden Deaths” Due to Myocarditis


Dr. John Gerrard, the Chief Health Officer of Queensland, made an admission that we’ve screamed from the rooftops for months now.

The rise in cardiac-related issues, particularly myocarditis.

Gerrard commented during a press conference:

“It does concern us when there are deaths at home,” Gerrard mentioned. “We’re seeing reports of people having an illness for a short period and then sudden deaths.”

He noted reports of myocarditis elsewhere in Australia and around the world.

“We are certainly keeping a close eye on particularly when there are deaths being investigated,” he reiterated.

In a recently published study, further evidence was presented of vaccine-induced myocarditis in adolescents.

As stated in the European Journal of Clinical Investigation:


Cases of myo/pericarditis (n = 253) included 129 after dose 1 and 124 after dose 2; 86.9% were hospitalized. Incidence per million after dose two in male patients aged 12–15 and 16–17 was 162.2 and 93.0, respectively. Weighing post-vaccination myo/pericarditis against COVID-19 hospitalization during delta, our risk-benefit analysis suggests that among 12–17-year-olds, two-dose vaccination was uniformly favourable only in nonimmune girls with a comorbidity. In boys with prior infection and no comorbidities, even one dose carried more risk than benefit according to international estimates. In the setting of omicron, one dose may be protective in nonimmune children, but dose two does not appear to confer additional benefit at a population level.


Our findings strongly support individualized paediatric COVID-19 vaccination strategies which weigh protection against severe disease vs. risks of vaccine-associated myo/pericarditis. Research is needed into the nature and implications of this adverse effect as well as immunization strategies which reduce harms in this overall low-risk cohort.

And given the high inoculation rate, the VAERS reporting system likely underreports the number of myocarditis cases.

Despite countless studies noting the concern of vaccine-induced myocarditis, some individuals still deny the validity of this severe adverse reaction.

Preprint Study Shows Increased Risk of Myocarditis Following Sequential COVID-19 Injections; Strongest Association in Males Under 40

NEW STUDY: Hong Kong Data Shows SIGNIFICANT Increased Risk of Acute Myocarditis/Pericarditis in Adolescent Males Following Comirnaty COVID-19 Jab

STUDY: American Heart Association Journal Shows 97.8% of Adolescents & Young Adults With Suspected Myocarditis Received mRNA COVID-19 Jab

Yet, this dangerous medical experiment is still available for children as young as five-years-old in many countries.


Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Hey, Noah here!

Wondering where we went?

Read this and bookmark our new site!

See you over there!

Thanks for sharing!